Elan Corp. reported continuing losses in its third quarter results Wednesday, but its battered shares rose as analysts pointed to signs that the pharmaceutical firm's tough restructuring plans were the red ink.
Struggling pharmaceutical firm elan reports third quarter losses foresees recovery.